
Tim McCutcheon
THE TRANSFORMATION of Ovoca Bio into Talisman Metals was due to be voted through at the EGM this week. It is clear that investors have significant faith in the latest chapter for Ovoca, which looks set to considerably broaden its horizons under CEO Tim McCutcheon. Having sold its remaining interest in its failed biopharmaceutical business,… Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!














